Dapagliflozin Tablet, Film Coated
Product Images NDC 72205-432

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 72205-432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dapagliflozin-10mg-30s-container-label (Dapagliflozin 10mg 30s Container Label)

Label for Dapagliflozin Tablets 10 mg film-coated tablets, available in a 30-tablet package. The label includes storage instructions, manufacturer information (MSN Laboratories Private Limited, India), and distributor details (Novadoz Pharmaceuticals LLC, NJ). It features barcode and NDC 72205-433-01 along with a pharmacist instruction to dispense the medication guide.*

FDA Label Image

Dapagliflozin-10mg-500s-container-label (Dapagliflozin 10mg 500s Container Label)

Label for Dapagliflozin Tablets 10 mg film coated tablets. The label indicates a package size of 500 tablets, manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Storage instructions and a pharmacist dispensing note are also included.*

FDA Label Image

Dapagliflozin-10mg-90s-container-label (Dapagliflozin 10mg 90s Container Label)

Dapagliflozin Tablets 10 mg film coated, bottle label with NDC 72205-433-03. The label states a quantity of 90 tablets and the manufacturer as MSN Laboratories Private Limited, India. Distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. It includes storage instructions and a note for pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Dapagliflozin-5mg-30s-container-label (Dapagliflozin 5mg 30s Container Label)

Label for Dapagliflozin Tablets 5 mg, film-coated oral tablets, in a 30-tablet package. The label includes storage instructions, manufacturer MSN Laboratories Pvt Ltd, and distributor Novadoz Pharmaceuticals LLC. It also displays NDC 72205-432-01 and a pharmacist advisory to dispense the Medication Guide with the product.*

FDA Label Image

Dapagliflozin-5mg-500s-container-label (Dapagliflozin 5mg 500s Container Label)

Label for Dapagliflozin Tablets 5 mg, film-coated oral tablets. The label indicates the quantity of 500 tablets and states it is Rx only. Manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Includes storage instructions and pharmacist dispensing note. Barcodes and NDC 72205-432-02 are visible.*

FDA Label Image

Dapagliflozin-5mg-90s-container-label (Dapagliflozin 5mg 90s Container Label)

Dapagliflozin Tablets 5 mg film-coated oral tablets label showing 90 tablets per bottle. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. The label includes storage instructions, a pharmacist's dispensing note, and multiple barcodes. NDC: 72205-432-03.*

FDA Label Image

Fig1 (Dapagliflozin Figure 01)

A scatter plot with dose-response curves showing the relationship between dapagliflozin dose (mg) on the x-axis and CFB in 24-hour urinary glucose (g) on the y-axis. The plot distinguishes observed values for healthy subjects and subjects with T2DM, with fitted lines for each group demonstrating the dose effect on urinary glucose excretion.*

FDA Label Image

Figure-02 (Dapagliflozin Figure 02)

A line graph depicting HbA1c (%) adjusted mean change from baseline over 24 weeks in a study. The x-axis represents study weeks (0 to 24), and the y-axis shows HbA1c change percentages. Three groups are plotted: Dapagliflozin 10 mg plus Metformin, Dapagliflozin 10 mg alone, and Metformin alone, with values decreasing over time. The graph includes a separate panel for Week 24 (LOCF) with confidence intervals.*

FDA Label Image

Fig-3 (Dapagliflozin Figure 03)

This line graph depicts adjusted mean change from baseline HbA1c (%) over a 24-week study period comparing Dapagliflozin 10 mg plus Metformin versus Placebo plus Metformin. The x-axis represents study weeks, and the y-axis shows HbA1c percentage change. The Dapagliflozin group shows a greater reduction in HbA1c compared to placebo. A right-side bar graph presents adjusted mean change from baseline at Week 24 with 95% confidence intervals for both groups.*

FDA Label Image

Dapagliflozin-figure-04 (Dapagliflozin Figure 04)

A line graph comparing the percentage of patients with events over 60 months post-randomization for Dapagliflozin tablets versus placebo. The x-axis represents months from randomization, and the y-axis shows the percentage of patients with events, with Dapagliflozin showing a lower event rate over time compared to placebo. A table below the graph displays the number of patients at risk for each group over time.*

FDA Label Image

Dapagliflozin-figure-05 (Dapagliflozin Figure 05)

A line graph comparing the cumulative percentage of patients with events over 60 months between Dapagliflozin and Placebo groups. The x-axis shows months from randomization, and the y-axis shows the percentage of patients with events. Dapagliflozin line is consistently below the placebo line, indicating fewer events over time. Patient risk numbers at different time points are shown below the x-axis for both groups.*

FDA Label Image

Str (Dapagliflozin Structure)

Chemical structure diagram of dapagliflozin, showing the molecular arrangement including multiple hydroxyl groups, aromatic rings, and a chlorine atom substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.